Melanoma Research Alliance Foundation

Analysis

Melanoma Research Alliance Foundation is a registered charity in United States, based in Washington, DC. It received its IRS tax-exemption ruling in January 2009, 17 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a supporting organisation (type i) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Melanoma Research Alliance Foundation reported income of $9.3m and spending of $10.3m, spending 111% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $22.5m to $9.3m (-59%), an average of -20% a year. The sharpest change came in the year to December 2020, when income dropped by 64%. Over the whole period it spent 112% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Melanoma Research Alliance Foundation sits at the 83rd percentile: it is larger than about 83% of them. Against every charity in United States with reported income it ranks in the 95th percentile, and in the 86th percentile within DC. Charities of a similar size with the same main cause include Dave Purchase Project ($9.3m), Public Health Accreditation Board ($9.3m) and Sharsheret Inc ($9.3m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 92% of the total. Compensation of current officers, directors and key employees was $1.0m (9.8% of expenses). Other salaries and wages came to $732k. At year end it held assets of $24.5m against liabilities of $11.5m, net assets of $13.0m. It reported 12 employees.

Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.